Premium growing double-digit
Net premium income grew 18.9% year on year (FY2025 → FY2026).
Importance 37 / 95 · growth
The strongest observations the engine found, ranked. Every line is generated from the filed numbers by a fixed rule — no opinion, no estimate.
Net premium income grew 18.9% year on year (FY2025 → FY2026).
Importance 37 / 95 · growth
Classified by the exchange under Financial Services › Financial Services › Insurance › Life Insurance.
Peer set used on this page: 4 life insurance.
Net premium rose 18.9% in FY2026, from ₹84,060 cr to ₹99,956 cr, and net profit rose 2.4%. Only two years of annual results are available, so a longer-term growth rate can't be calculated yet.
Net premium income grew 18.9% year on year (FY2025 → FY2026).
Rule INSURER_PREMIUM_GREW_YOY
In Q2 FY27 (Jul–Sep 2026), net premium was ₹26,878 cr (up 8.2% on the same quarter last year) and net profit ₹549 cr (up 11.0%).
Quarterly results, the trailing-twelve-months snapshot, and verified corporate actions — kept separate from each other and from the annual story above. Every figure traces to a filed number; nothing here is external news or commentary.
Q2 FY27 net profit was ₹549 cr, up 11.0% from ₹495 cr a year earlier.
Rule QTR_PROFIT_GROWTH_YOY
Q2 FY27 claims ratio was 57.7%, up 3.46 percentage points from 54.3% a year earlier.
Rule QTR_INSURER_CLAIMS_RATIO_CHANGE_YOY
Q2 FY27 net premium was ₹26,878 cr, up 33.9% from ₹20,078 cr in the previous quarter (Q1 FY27).
Rule QTR_REVENUE_SEQUENTIAL_CHANGE
| Quarter | Net premium | YoY | Net profit | YoY |
|---|---|---|---|---|
| Q4 FY25 | 23,861 | — | 814 | — |
| Q1 FY26 | 17,178 | — | 594 | — |
| Q2 FY26 | 24,848 | — | 495 | — |
| Q3 FY26 | 30,245 | — | 577 | — |
| Q4 FY26 | 27,684 | +16.0% | 805 | −1.1% |
| Q1 FY27 | 20,078 | +16.9% | 725 | +22.0% |
| Q2 FY27 | 26,878 | +8.2% | 549 | +11.0% |
Trailing twelve months to 30 Sept 2026 · sum of the last 4 contiguous quarters
ROE was 13.7% in FY2026 (14.2% in FY2025); net margin 2.2%; expenses were 10.6% of premium.
The metrics this section charts aren't mapped for this company's sector yet — see the data-coverage note in section 10.
Net worth was ₹19,086 cr in FY2026, against ₹16,985 cr in FY2025.
Leverage and cash generation over the loaded history are shown above.
Within its 4-company Life Insurance peer group, it ranks 2 of 3 on return on equity and 1 of 3 on revenue growth (among peers with data). Its P/E of 68.8 compares with a peer median of 65.4.
Ranked against 4 life insurance (FY2026, consolidated). No peer-relative rule fired for this company.
SBILIFE · 1st of 3 · set median 11.3%
SBILIFE · 2nd of 3 · set median 13.7%
SBILIFE · 3rd of 4 · set median 65.4×
On the trailing twelve months. Last full year: P/E 74.0× · P/S 1.6× · ROE 13.7%.
The share price is down 10.1% over 1 year, up 28.0% over 3 years (8.6% a year) and up 54.2% over 5 years (9.0% a year). These are price changes excluding dividends, adjusted for splits and bonuses, to 20 Nov 2026; it is 13.6% below its 52-week high.
Long-term price performance is shown above.
Price-action indicators as of 2026-11-20. Secondary to the fundamentals above — included for timing context, not as a signal.
Observations the engine tagged watch or deteriorating — prompts for your own research, not conclusions.
Nothing is flagged for review for this company.
The full statements, kept deliberately secondary. Every figure traces to a BSE Integrated Filing (inline XBRL); ratios are recomputed from the normalised facts.
| Metric | FY25 | FY26 |
|---|---|---|
| Revenue | 84,060 | 99,956 |
| Total income | 1,17,119 | 1,12,966 |
| Gross premium income | 84,985 | 1,01,286 |
| Net premium income | 84,060 | 99,956 |
| Benefits paid (net) | 48,902 | 54,323 |
| Profit before tax | 2,495 | 2,537 |
| Net profit | 2,413 | 2,470 |
| EPS (₹) | 24.1 | 24.6 |
| Net worth | 16,985 | 19,086 |
| Investments | 4,47,467 | 4,86,367 |
| Operating cash flow | 25,547 | 34,523 |
| Ratio | FY25 | FY26 |
|---|---|---|
| Growth | ||
| Net premium growth YoY | — | 18.9 |
| Profit growth YoY | — | 2.4 |
| Profitability & efficiency | ||
| Net margin % | 2.1 | 2.2 |
| Expense ratio % | 9.7 | 10.6 |
| Benefits / premium % | 58.2 | 54.3 |
| Return on equity % | 14.2 | 13.7 |